Advil-maker Haleon investing $54.2 million in its Richmond plant
The maker of Advil, Tums and Sensodyne toothpaste is investing $54.2 million to upgrade its global research and development facility in Richmond. Why it matters: The upgrades could lead to more local jobs and help establish the region as a "pharma corridor,
Drugmaker Haleon will spend $54 million upgrading Richmond lab
Based in the United Kingdom, Haleon makes consumer health care products, including Advil, Centrum Multivitamin and Aquafresh Toothpaste.
Haleon Will Invest $54.2M In A Richmond, Virginia, R&D Facility
The consumer health company site will launch an internship program with the state government and Virginia Commonwealth University
Haleon to invest $54 million in US R&D centre to boost product innovation
Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre in Richmond, U.S., aiming to boost its pipeline for new product innovations.
Richmond rises as pharma hub: Haleon invests $54 million and launches paid internship program
Richmond is cementing its status as a hub for pharmaceutical innovation, with Gov. Glenn Youngkin dubbing the region a “Pharma Corridor” during Monday’s announcement of major investments and opportunities at Haleon,
What Haleon's $54.2 million investment means for Richmond
Haleon, a global company behind home healthcare products like Advil, Tums and Aquafresh, announced plans to upgrade its Richmond research and development facility.
UK pharmaceutical company Haleon expanding R&D facility in Richmond
The UK-based pharmaceutical company Haleon will invest $54.2 million to upgrade its R&D facility in Richmond, which has helped birth or grow products such as Advil, Emergen-C and Robitussin.
$54M in upgrades planned at Haleon R&D facility in Northside
The UK-based consumer healthcare company will be modernizing its facility along Brook Road, where it conducts R&D for such brands as Sensodyne toothpaste, Centrum multivitamins and Flonase nasal spray.
Pharma company to invest $54.2M in Richmond R&D facility
Listen to this article Pharmaceutical company Haleon will invest $54.2 million to upgrade its research and development facility in Richmond and launch an internship program in partnership with state government and Virginia Commonwealth University,
Haleon to invest $54 mln in US R&D centre to boost product innovation
Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre in Richmond, U.S., aiming to boost its pipeline for new product innovations.
WRIC2d
Haleon to expand Richmond research and development facility
The expansion was announced in a press conference held on Monday, Jan. 27, detailing how Haleon, a global health company, plans to invest $54.2 million for upgrades to the Richmond facility.
Hosted on MSN2d
Richmond consumer health facility announces $54 million dollar upgrade
Haleon, a global consumer health company behind products like Advil, Aquafresh and Polident, announced a $54.2 million ...